Добавил:
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Color Atlas of Neurology

.pdf
Скачиваний:
201
Добавлен:
11.08.2013
Размер:
18.87 Mб
Скачать

Appendix

Table 23 Causes of chronic daily headache (p. 182)

Type of Headache

Symptoms and Signs/Syndromes

 

 

Primary headache

 

Chronic tension

See p. 182

headache

 

Migraine

Mild to severe, often unilateral pain (transformed migraine). Additional migraine at-

 

tacks (p. 184)

Atypical facial pain

Unilateral or bilateral pain, often predominantly felt in the nasolabial or palatal region,

 

often very severe. Unresponsive to a wide variety of medical and surgical therapies.

 

Normal findings on a wide variety of diagnostic tests (“diagnosis of exclusion”)

Secondary headache

Posttraumatic, drug-induced, vascular (p. 182), intracranial mass, hydrocephalus, sinusi-

 

tis, parkinsonism, cervical dystonia, myoarthropathy of the masticatory apparatus,1

 

mental illness (depression, schizophrenia, hypochondria), cervical spine lesions

 

(degenerative lesions, fractures, Klippel–Feil syndrome), Down syndrome, basilar im-

 

pression, osteoporosis, skull metastasis, spondylitis, rheumatoid arthritis, lesions of cer-

 

vical spinal cord/meningismus (tumor, hemorrhage, syringomyelia, cervical myelopathy,

 

von Hippel–Lindau syndrome, meningitis, carcinomatous meningitis, intracranial hypo-

 

tension)

 

 

1 Temporomandibular joint dysfunction, oromandibular dysfunction.

Table 24 Prognostic factors in epilepsy (p. 198)

Favorable Prognostic Factors

Unfavorable Prognostic Factors

 

 

One seizure type

Multiple seizure types

No interictal neurological deficit

Interictal neurological deficit

Older age of onset

Younger age of onset

Seizures secondary to a treatable disease

Spontaneous seizures

Individual seizures of short duration

Status epilepticus

Frequent seizures

Infrequent seizures

Good response to anticonvulsants

Poor response to anticonvulsants

 

(Neville, 1997)

Appendix

373

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Appendix

374

Appendix

Table 25 Causes of syncope (p. 200)

Cause

Underlying Condition/Trigger

 

 

Cardiac

Arrhythmia (bradyrhythmia, tachyrhythmia, or reflex arrhythmia), heart disease (e. g.,

 

cardiomyopathy, myxoma, mitral stenosis, congenital malformation, pulmonary em-

 

bolism)

Hemodynamic

Hypovolemia, hypotension (vasovagal as an emotional reaction to pain, anxiety, sudden

 

shock, sight of blood; hypotension from prolonged standing, heat, exhaustion, alcohol;

 

multiple system atrophy; polyneuropathies, e. g., amyloid, hereditary, toxic; polyradicu-

 

lar neuropathies/Guillain–Barré syndrome; antihypertensive agents, nitrates, other

 

drugs; postural orthostatic tachycardia syndrome = POTS; paraplegia above T6)

Cerebrovascular

Subclavian steal syndrome, basilar migraine, Takayasu disease

Metabolic

Hypoglycemia, hyperventilation, anemia, anoxia, postprandial (older individuals)

Miscellaneous

Coughing fit (cough syncope = tussive syncope = laryngeal syncope), micturition (mic-

 

turition syncope), defecation, prolonged laughing (“laughing fit”, geloplegia), glos-

 

sopharyngeal neuralgia, affect-induced respiratory convulsion in childhood (breath-

 

holding spells), pop concerts (teenage females), lying in supine position during preg-

 

nancy (supine syndrome)

 

(Bruni, 1996; Lempert, 1997)

Table 26 Causes of sudden falling without loss of consciousness (p. 204)

Type of Fall/Pathogenesis

Cause

Features

 

 

 

Drop attack

TIA1 in vertebrobasilar territory

Usually accompanied by dizziness,

 

 

diplopia, ataxia, or paresthesias

 

TIA in anterior cerebral artery

Seen when the two anterior cere-

 

territory

bral arteries arise from a common

 

 

trunk

 

Colloid cyst of 3rd ventricle

Position-dependent headache

 

Posterior fossa tumor

Sudden fall after flexion of neck

Parkinsonism

Parkinson disease, multiple

See p. 206 f

 

system atrophy

 

Muscle weakness

Myopathy, Guillain–Barré syn-

See p. 50 f

 

drome, polyneuropathy, spinal

 

 

lesions

 

Spinal or cerebellar ataxia, gait

Funicular myelosis, cerebellar

See specific diseases

apraxia

lesions, metabolic encephalo-

 

 

pathies, hydrocephalus, lacunar

 

 

state, cervical myelopathy, multi-

 

 

ple sclerosis

 

Cryptogenic

Unknown

Occurs in women over 40 while

 

 

walking

Vestibular disorder

Ménière disease (vestibular drop

Dizziness, nausea, nystagmus, tin-

 

attack Tumarkin otolithic crisis);

nitus. Vestibular drop attacks may

 

occasionally due to otitis media,

occur in isolation

 

toxic or traumatic causes

 

Cataplexy

Loss of muscle tone triggered by

Alone or with narcolepsy

 

emotional stimuli (fright, laughter,

 

 

anger)

 

1 Transient ischemic attack.

 

 

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

 

Appendix

 

Table 27 Diagnostic criteria for multiple sclerosis (pp. 216, 218)

 

 

Manifestations

Additional Information Needed for Diagnosis

 

 

Two or more episodes; objective eviden-

None

ce1 of 2 or more lesions

 

Two or more episodes; objective evidence

Disseminated lesions (MRI2) or two or more MS-typical lesions

of 1 lesion

(MRI and positive CSF tests3) or relapse4

One episode; objective evidence of 2 or

Dissemination of lesions over time (MRI5) or relapse

more lesions

 

One episode; objective evidence of 1 le-

Disseminated lesions (MRI2) or two or more MS-typical lesions

sion (monosymptomatic syndrome)

(MRI + positive CSF findings3) + dissemination of lesions over

 

time (MRI5) or relapse

Gradual worsening of neurological

Positive CSF findings3 + disseminated lesions6 or pathological

manifestations suggestive of MS

VEP + 4–8 cerebral lesions7 + dissemination of lesions over time

 

(MRI5) or continuous progression for 1 year

(McDonald et al., 2001)

1 MRI, CSF, visual evoked potentials (VEP). 2 For special criteria, see McDonald et al., 2001. 3 Oligoclonal immunoglobulin, elevated IgG index. 4 Topographic-anatomic classification differs from that of previous episodes. 5 Follow-up examination after an interval of at least 3 months; for special criteria, see McDonald et al., 2001. 6 Nine or more cerebral lesions or two or more spinal lesions or 4–8 cerebral lesions + 1 spinal lesion. 7 In patients with fewer than 4 cerebral lesions, at least 1 additional spinal lesion must be observed by MRI.

Table 28 Therapeutic guidelines for meningoencephalitis (p. 224)

Clinical Features

Additional Findings

Treatment1

 

 

 

Previously healthy patient

Gram-positive cocci in CSF

Vancomycin + cephalosporin

 

Gram-negative cocci in CSF

Penicillin G

 

Gram-positive bacilli in CSF

Ampicillin or penicillin G +

 

 

aminoglycoside3

 

Gram-negative bacilli in CSF

Cephalosporin2 + aminoglycoside3

Previously healthy patient

Negative CSF Gram stain5

Bacterial infection suspected:

 

 

cephalosporin2. Age !50 years +

 

 

ampicillin

 

 

Viral infection suspected: influenza

 

 

A, amantadine or rimantadine;

 

 

herpes simplex (p. 236); cytome-

 

 

galovirus (p. 244); poliovirus

 

 

(p. 242); HIV (p. 241); varicella

 

 

zoster (p. 239)

Septic focus (e. g., mastoiditis),

Supportive evidence from imaging

Vancomycin + cephalosporin2

neurosurgery, head trauma

study, e. g., CT with bone windows

 

Immune deficiency/immunosup-

(possible) Brain stem signs, Gram-

Ampicillin + ceftazidime

pressant therapy4

negative bacilli in CSF

 

Nosocomial infection

(possible) Gram-negative bacilli in

Cephalosporin2 + e. g., oxacillin or

 

CSF

fosfomycin + aminoglycoside3

Focal neurological signs

Temporal lobe process demon-

Acyclovir (p. 236)

 

strated by EEG, CT and/or MRI

 

Spinal and radicular pain

Spinal epidural abscess confirmed

Cephalosporin2 + (e. g.) oxacillin

 

by imaging study (MRI, myelogra-

or fosfomycin + aminoglycoside3.

 

phy, or CT)

Surgery

Neonate ("3 months of age)

Negative CSF Gram stain

Ampicillin + cephalosporin2

1 Drugs recommended by Quagliarello and Scheld (1997). 2 E.g., cefotaxime or ceftriaxone. 3 Gentamycin or tobramycin. 4 Predisposes to tubercular, fungal, and other opportunistic infections (pp. 233, 245 f). 5 Aseptic/viral meningitis, p. 234.

Appendix

375

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Appendix

Appendix

Table 29 Bacteria commonly causing meningitis and meningoencephalitis (p. 226)

Pathogen

Portal of Entry/Focus

Clinical Features

 

 

 

Pneumococcus (S. pneumoniae/

Nasal and pharyngeal mucosa,

Meningitis may be accompanied or

Gram+ extracellular diplococ-

head trauma, neurosurgical

preceded by sinusitis, otitis media or

cus) adults1

procedures, external CSF

pneumonia. Posttraumatic meningitis

 

drainage

may occur several years after trauma; re-

 

 

current meningitis (CSF leak? Im-

 

 

munodeficiency?). Course may be hyper-

 

 

acute (nonpurulent meningitis2), acute or

 

 

subacute (days to weeks). Epileptic

 

 

seizures. Risk of brain abscess, subdural

 

 

empyema or cerebral vasculitis

Meningococcus (N. meningitid-

Nasopharynx

Hyperacute course with sepsis,

is3/Gramintracellular diplo-

 

adrenocortical insufficiency and consump-

coccus) children and ado-

 

tion coagulopathy (Waterhouse–Frider-

lescents4

 

ichsen syndrome). Petechial or confluent

 

 

cutaneous hemorrhages. Myocarditis/peri-

 

 

carditis

Haemophilus influenzae (Gram

Nasal and pharyngeal mucosa

Usually type B. May be accompanied or

bacillus) children and ado-

 

preceded by sinusitis, otitis media, or

lescents

 

pneumonia

Listeria (L. monocytogenes/

Gastrointestinal tract (con-

Focal neurological deficits, particularly

Gram+/organism difficult to

taminated food, e. g., dairy

brain stem encephalitis (rhombencephali-

identify) neonates5, adults

products or salads)

tis), are commonly seen.

!50 years of age

 

Predisposing factors: pregnancy, old age,

 

 

alcoholism, immune suppression, primary

 

 

malignancy. CSF findings are extremely

 

 

variable (“mixed cell picture”)

Staphylococcus (S. aureus/

Endocarditis, head trauma, ex-

In association with sepsis, i. v. drug use,

Gram+) neonates and adults

ternal CSF drainage, lumbar

alcoholism, diabetes mellitus, primary

Enterobacter (Gram/bacilli)

puncture, urinary tract,

malignancy

neonates

spondylodiskitis

 

M. tuberculosis (acid-fast bacil-

Extracerebral organ tuberculo-

See p. 232

lus)

sis

 

 

 

 

Gram+ = Gram-positive; Gram= Gram-negative.

1 Age !18 years. 2 Very rapidly progressive meningitis, low cell count and high total protein and lactate levels in CSF, and CSF smear culture containing large quantities of bacteria. 3 Group A, Central Africa, South America; Group B, Europe; Group C, North America; type may change. 4 Age 3 months to 18 years. 5 Age "3 months.

Table 30 Viruses causing CNS infection (p. 234)

 

 

 

Common

Occasional

Rare

 

 

 

 

 

 

 

 

 

Meningitis

 

 

 

 

 

Enteroviruses1,3, arboviruses2,3,

HSV type 14, LCMV3, mumps

Adenoviruses4, CMV4, Epstein–Barr virus

 

 

 

HIV5, HSV type 24

virus3

(EBV)4, influenza virus A+B3, measles

 

 

 

 

 

virus3, parainfluenza virus3, rubella virus3,

 

 

 

 

 

varicella-zoster virus (VZV)4

 

 

 

Encephalitis, myelitis

 

 

 

 

 

Arboviruses, enteroviruses,

CMV, EBV, HIV, measles virus3,

Adenoviruses, influenza A, LCMV, parain-

 

 

 

HSV type 1, mumps virus

VZV

fluenza virus, rabies virus3, rubella virus,

 

 

 

 

 

HTLV-I5,6

376

1

Poliovirus 1–3, coxsackievirus (B5, A9, B3, B4, B1, B6), echovirus (7, 9, 11 30, 4, 6, 18, 2, 3, 12, 22), enterovirus

 

(70, 71). 2 Arthropod-borne viruses, including alphaviruses, flaviviruses, pestiviruses, bunyaviruses, and orbiviruses. 3 RNA virus. 4 DNA virus. 5 Retrovirus. 6 Human T-cell lymphotropic virus type I causes myelitis.

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

 

 

 

 

 

Appendix

 

 

 

 

 

Table 31 Grades of malignancy of brain tumors (p. 264)

 

 

 

 

 

 

 

 

 

Tumor

Grade I

Grade II

Grade III

Grade IV

 

 

(benign)

(semi-

(malig-

(malig-

 

 

 

benign)

nant)

nant)

 

 

 

 

 

Neuroepithelial tumors

 

 

 

 

Astrocytoma

 

 

 

 

! Fibrillary, protoplasmic, gemistocytic astrocytoma

 

+++

++

 

!

Anaplastic astrocytoma

 

 

+++

 

!

Glioblastoma ( = glioblastoma multiforme)

 

 

 

+++

!

Pilocytic astrocytoma

+++

 

+

 

!

Pleomorphic xanthoastrocytoma

 

+++

++

 

Oligodendroglioma

 

 

 

 

!

Oligodendroglioma

 

+++

 

 

!

Anaplastic oligodendroglioma

 

 

+++

 

Ependymoma

 

 

 

 

! Ependymoma (cellular, papillary, epithelial)

++

+++

++

 

!

Anaplastic ependymoma

 

 

+++

 

Mixed glioma

 

 

 

 

!

Oligoastrocytoma

 

+++

 

 

!

Anaplastic oligoastrocytoma

 

 

+++

 

Choroid plexus tumors

 

 

 

 

!

Plexus papilloma

+++

 

 

 

!

Plexus carcinoma

 

 

+++

++

Neuronal/mixed neuronal-glial tumors

 

 

 

 

!

Gangliocytoma

+++

 

 

 

!

Ganglioglioma

 

+++

 

 

!

Anaplastic ganglioglioma

 

 

+++

 

Pineal tumors

 

 

 

 

!

Pineocytoma

+++

++

 

 

!

Pineoblastoma (PNET)

 

 

 

+++

Embryonal tumors

 

 

 

 

! Primitive neuroectodermal tumor (PNET), see p. 260

 

 

 

+++

!

Neuroblastoma

 

 

 

+++

Cranial nerve tumors

 

 

 

 

!

Schwannoma

+++

 

 

 

Meningeal tumors

 

 

 

 

!

Meningioma

+++

 

 

 

!

Anaplastic meningioma

 

 

+++

 

Blood vessel tumors

 

 

 

 

!

Hemangiopericytoma

 

+++

++

 

!

Glomus tumor

+++

 

 

 

Lymphoma

 

 

 

 

!

Primary CNS lymphoma

 

 

++

+++

Germ cell tumors

 

 

 

 

!

Germinoma

 

 

+++

 

Intraand suprasellar tumors

 

 

 

 

!

Pituitary adenoma

+++

 

+

 

!

Craniopharyngioma

+++

 

 

 

Metastatic tumors

 

 

 

+++

 

 

(Kleihues et al., 1993 and Krauseneck, 1997)

+++, Common; ++, Rare; +, Very rare.

Appendix

377

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Appendix

Appendix

Table 32 Karnofsky performance scale for quantification of disability (p. 264)

General Condition

%

Comments

 

 

 

Patient can perform normal daily activities and

100

Normal; no complaints; no evidence of disease

work without impairment

 

 

No specific treatment required

90

Able to carry on normal activity; minor impair-

 

 

ment

 

80

Normal activity with effort; some impairment is

 

 

clearly evident

Patient cannot work; can meet most personal

70

Cares for self; cannot perform normal activities

needs, but needs some degree of assistance; can

 

or work

be cared for at home

60

Needs occasional assistance, but can meet most

 

 

 

personal needs

 

50

Needs considerable assistance and frequent

 

 

medical care

Patient cannot care for self; needs to be cared for

40

Disabled; requires special care and assistance;

in a hospital, nursing home, or at home by a

 

home nursing care still possible

nurse/family members. Disease may progress

 

 

rapidly

30

Severely disabled; hospitalization indicated al-

 

 

 

though death not imminent

 

20

Gravely ill; hospitalization necessary

 

10

Moribund

 

 

 

Table 33 Glasgow coma scale (p. 266)

I

 

II

 

III

 

Eye Opening

Score

Best Verbal Response

Score

Best Motor Response (arms)

Score

 

 

 

 

 

 

 

 

 

 

Obeys commands

6

 

 

Oriented

5

Selectively avoids painful stimuli

5

Spontaneous

4

Confused

4

Withdraws limb from painful

4

 

 

 

 

stimuli

 

To speech

3

Single words

3

Flexes limb in response to painful

3

 

 

 

 

stimuli

 

To pain

2

Meaningless utterances

2

Extends limb in response to pain-

2

 

 

 

 

ful stimuli

 

No response

1

No response

1

No response

1

 

 

 

 

(Teasdale, 1995)

The scores in columns I, II, and III are summed to yield the overall value.

GCS 13–15 = mild head trauma; GCS 9–12 = moderate head trauma; GCS 3–8 = severe head trauma.

378

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Appendix

Table 34 Criteria for assessment of head trauma (p. 266)

Severity (GCS)1

Risk of

Symptoms and Signs 3

 

Secondary

 

 

Injury2

 

 

 

 

Mild (13–15)

Low

Impairment of consciousness lasting !1 hour

 

 

Asymptomatic (or, at most: headache, dizziness, bruises, and lacera-

 

 

tions)

Moderate (9–12)

Moderate

Impairment of consciousness at time of accident or thereafter, last-

 

 

ing between 1 and 24 hours

 

 

Increasingly severe headache

 

 

Alcohol/drug intoxication

 

 

No reliable description of accident. Multiple trauma, severe facial injur-

 

 

ies, basilar skull fracture, suspicion of depressed skull fracture or open

 

 

head injury. Posttraumatic epileptic seizure, vomiting, amnesia

 

 

Age !2 years (except in minor accidents), possibility of child abuse

Severe (3–8)

High

Impairment of consciousness lasting !24 hours + brain stem syn-

 

 

drome or

 

 

Impairment of consciousness lasting "24 hours or

 

 

Posttraumatic psychosis lasting "24 hours

 

 

Impairment of consciousness not due to alcohol/substance abuse/medi-

 

 

cations, and not a postictal or metabolic phenomenon

 

 

Focal neurological signs

 

 

Depressed skull fracture, open head injury

 

 

 

(White and Likavec, 1992) 1 Glasgow Coma Scale. 2 Patients with one or more manifestations from the list at right belong to the corresponding risk group. 3 Criteria for assessment of severity are in bold type.

Table 35 Late complications of head trauma (p. 268)

Complications

Clinical Features

Remarks

 

 

 

Posttraumatic syn-

Headache, nausea, vertigo, orthostatic

Usually follows mild head trauma; may

drome

hypotension, depressed mood, irritability,

cause significant psychosocial impairment

 

fatigue, insomnia, impaired concentration

 

Chronic subdural

Headache, behavioral change, focal signs

Usually follows mild trauma (predisposing

hematoma (SDH)

 

factors: old age, brain atrophy, alco-

 

 

holism)

Subdural hygroma

Same as in chronic SDH

Symptoms may improve when the patient

 

 

is lying down and worsen on standing

CSF leak

Drainage of CSF from the nose or ear; risk

CSF rhinorrhea worsens on head flexion.

 

of recurrent meningitis, brain abscess

CSF otorrhea indicates a laterobasal skull

 

 

fracture

Hydrocephalus

Headache, behavioral change, urinary in-

Normal pressure hydrocephalus, venous

 

continence

sinus thrombosis

Epilepsy

Focal/generalized seizures

May arise years after head trauma

Encephalopathy

Behavioral changes

See p. 122ff. Types include septic en-

 

 

cephalopathy, punch-drunk en-

 

 

cephalopathy (p. 302, Table 44)

Critical illness neu-

Prolonged ventilator dependence, weak-

Associated with sepsis and multiple organ

ropathy and my-

ness

failure

opathy

 

 

Heterotopic ossifi-

Restricted mobility of joints, pain

Due to muscle trauma

cation (myositis

 

 

ossificans)

 

 

Complications of

Bed sores, peripheral nerve lesion, joint

Ensure proper positioning and frequent

immobility

malposition

changes of position (especially of para-

 

 

lyzed limbs)

 

 

 

Appendix

379

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Appendix

380

Appendix

Table 36 Spinal fractures (p. 272)

Fracture/Dislocation

Pathogenesis

Stability1

 

 

 

 

 

Cervical spine

 

 

 

 

!

Atlantoaxial dislocation

! Dislocation between C1 and C2

!

Unstable

!

Jefferson’s fracture2

!

Axial trauma

!

Unstable

!

Dens fracture

!

Hyperflexion

!

Unstable3

! Bilateral axis arch fracture4

!

Hyperflexion and distraction

!

Unstable

! Dislocation fracture of C3–7

!

Hyperflexion

!

Unstable

!

Lateral compression fracture

!

Flexion and axial compression

!

Stable

Thoracic spine, lumbar spine

 

 

 

 

!

Compression fracture

Fall (back, buttocks, extended legs),

!

Stable

 

 

direct trauma. These fractures may be

 

 

 

 

pathological (osteoporosis, myeloma,

 

 

!

Burst fracture

metastasis)

!

Stable

 

 

!

Dislocation fracture

 

 

!

Unstable

 

 

 

 

 

 

(Ogilvy and Heros, 1993; Sartor 2001)

1 At the time of injury. 2 Fracture of the ring of C1 due to compression between the occiput and C2. 3 May be overlooked if the dens is not displaced; sometimes stable. 4 Hangman’s fracture.

Table 37 Classification of traumatic transverse spinal cord syndrome (p. 274)

Loss of Function

Category

Features

 

 

 

Complete

A

No sensory or motor function, including in S4–5

Incomplete

B

No motor function. Sensory function intact below level of lesion,

 

 

including in S4–5

Incomplete

C

There is motor function below level of lesion; most segment-in-

 

 

dicating muscles have strength !3

Incomplete

D

There is motor function below level of lesion; most segment-in-

 

 

dicating muscles have strength "3

None

E

Normal motor and sensory function

 

 

 

(American Spinal Cord Injury Association Impairment Scale; Ditunno et al., 1994)

Table 38 Treatment of spinal trauma (p. 274)

Result of Trauma

Treatment Measures

 

 

Neck sprain/whiplash in-

Analgesics, application of heat/cold, immobilization (as brief as possible). Early in-

jury

itiation of active exercise therapy. Measures to prevent chronification

Fracture

Stable conservative (extension/fixation). Unstable surgery

Arterial dissection

Anticoagulation

Spinal cord trauma

Methylprednisolone (i. v.) within 8 hours of trauma (bolus of 30 mg/kg over 15

 

min, then 5.4 mg/kg/h for 23 hours). Monitor respiratory and cardiovascular func-

 

tion, bladder/bowel function; thrombosis prophylaxis, pain therapy, careful

 

patient positioning and pressure sore prevention. Transfer to specialized center

 

for rehabilitation of paraplegic patients (as indicated)

 

 

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

 

 

 

 

Appendix

 

Table 39 Clinical manifestations of spinal cord lesions (p. 282)

 

 

 

Features

Site of Lesion

Clinical Manifestations

 

 

 

 

 

Spinal cord transection

!

Cervical spinal cord

!

Quadriplegia

(p. 48)

!

Thoracic spinal cord

!

Paraplegia

 

!

Lumbar/sacral spinal

! Paraplegia/conus syndrome with paralysis of blad-

 

 

cord

 

der/rectum and saddle anesthesia

Lesion affecting a por-

!

Anterior root

! Flaccid paralysis, muscle atrophy, hyporeflexia (

tion of the spinal cord

 

 

 

segment-indicating muscles, see Table 2, p. 357)

(pp. 32, 50)

!

Posterior root

! Localized/radicular/referred pain, sensory deficit in

 

 

 

 

corresponding dermatome

 

!

Incomplete transverse

! Brown–Séquard syndrome, posterior column syn-

 

 

cord syndrome

 

drome, anterior horn syndrome, posterior horn

 

 

 

 

syndrome, central cord syndrome, anterior spinal

 

!

 

!

syndrome

 

Complete transverse

See p. 48

 

 

cord syndrome

 

 

Temporal course

!

Acute

!

Spinal shock

 

!

Chronic

!

Spasticity, sensory and autonomic dysfunction

 

 

 

 

 

Table 40 Malformations and developmental anomalies (p. 288)

Feature

Syndrome1

Comments2

 

 

 

Macrocephaly (ab-

Hydrocephalus (p. 290), hydranencephaly, megalencephaly

4th week/

normally large

(massively enlarged brain)

2nd to 4th month

head)

 

 

Craniostenosis

Turricephaly ( lambdoid and coronal suture; oxycephaly),

Before 4th year of life

(premature ossifi-

scaphocephaly ( sagittal suture; dolichocephaly, “long

 

cation of cranial

head”), brachycephaly ( coronal suture; “short head”)

 

sutures, p. 4)

 

 

Migration disorder

Schizencephaly (presence of cysts or cavities in the brain),

2nd to 5th month

(defective migra-

agyria (lissencephaly3, few or no convolutions), pachygyria

 

tion of neuroblasts

(broad, plump convolutions), heterotopia/dystopia (ectopic

 

into cortex)

gray matter)

 

Microcephaly (ab-

Micrencephaly (abnormally small brain)

5th week (primary),

normally small

 

perior postnatal (sec-

head)

 

ondary)

Dysraphism (neural

See p. 292

3rd to 4th week/

tube defect)

 

4th to 7th week

Chromosomal

Down syndrome (trisomy 21, mongolism), Patau syndrome

Genome mutation

anomaly

(trisomy 13), Edwards syndrome (trisomy 18), cri-du-chat

 

 

syndrome (deletion, short arm of chromosome 5), Klinefelter

 

 

syndrome (XXY), Turner syndrome (XO), fragile-X syndrome

 

Phakomatosis

See p. 294

 

Prenatal or peri-

Rubella, cytomegalovirus, congenital neurosyphilis, HIV/

 

natal infection

AIDS, toxoplasmosis

 

Mental retardation

A component of many syndromes (e. g., microcephaly, hy-

 

 

drocephalus, Down syndrome, perinatal or prenatal infec-

 

 

tion)

 

Cerebral lesion

Ulegyria (postanoxic corticomedullary scarring), poren-

Prenatal, perinatal or

 

cephaly (p. 290), hemiatrophy, infantile cerebral palsy

postnatal

 

(p. 288 f)

 

 

 

 

1 (Selected). 2 The times specified refer to the gestational and neonatal ages, respectively. 3 There are two forms of lissencephaly: type 1, Miller–Dicker syndrome (craniofacial deformity), and type 2 (pronounced heterotopia with Fukuyama muscular dystrophy).

Appendix

381

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Appendix

Appendix

Table 41 Age-related changes (p. 296)

Change

Sequelae

Elevated risk1 of

 

 

 

Accommodation

Presbyopia

 

Miosis

Light/convergence reaction

 

Cataract

Glare, visual acuity

Blindness

Hearing (inner ear)

Presbycusis

Deafness

Sense of smell/taste

Impaired sense of smell/taste

 

Body fat

volume of distribution for fat-soluble drugs2

Obesity

Total body water,

 

volume of distribution for water-soluble drugs2

Dehydration, hydro-

Thirst

 

 

penia

Arteries

Atherosclerosis, impairment of cerebral autoregula-

Stroke3, leukoaraiosis4,

 

tion and blood-brain barrier, decrease in cerebral

subcortical arterios-

 

blood flow, reduced tolerance of brain tissue to

clerotic encephalo-

 

ischemia and metabolic changes

pathy (p. 172), cerebral

 

 

 

amyloid angiopathy5,

 

 

 

atrial fibrillation, myo-

 

 

 

cardial infarction

Motor function

Mobility, reactivity, coordination, fine motor

Falls (p. 204), osteo-

 

control, muscle atrophy (especially thenar, dorsal in-

porosis, fear of falling/

 

terosseous, and anterior tibial muscles),

inactivity (avoidance of

 

muscle force, leg muscle tone, hypokinesis of

social contact, isola-

 

arms, gait impairment (p. 60)

tion)

Reflexes

Reflex movements (p. 42), palmomental reflex,

Falls

 

snout reflex, grasp reflex

 

Sensation

Pallhypesthesia in toe/knuckle region, position

Polyneuropathy, ataxia,

 

sense

falls

Brain atrophy

Senile forgetfulness6 (impairment of episodic

Alzheimer disease,

 

memory, p. 134)

leukoaraiosis4

Cerebral dopamine syn-

Stooped posture

Parkinsonism

thesis

 

 

 

Cerebral norepinephrine

 

 

Depression

Non-REM stage 4

Early awakening, insomnia

Sleep apnea syndrome

(p. 112)

 

 

 

 

 

 

 

(Resnick, 1998)

1 Risk of developing condition in old age. 2 Increased risk of drug side effects. 3 Especially due to border zone infarction, subdural hematoma (after relatively minor trauma). 4 Rarefaction of white matter seen as bilateral, usually symmetrical hypodensity on CT and as hyperintensity on T2-weighted MRI (FLAIR = fluid-attenuated inversion recovery sequence). 5 Increased risk of spontaneous intracranial hemorrhage (p. 176). 6 Benign senescent forgetfulness, age-associated memory impairment (AAMI).

382

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Соседние файлы в предмете Нормальная анатомия